Pathstone Holdings’s CryoPort CYRX Stock Holding History

Pathstone Holdings’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,903	Closed	-$184K	–	2309
2023 Q4	$184K	Buy	+11,903	New	+$156K	﹤0.01%	2074

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Pathstone Holdings's CYRX Position: Q1 2024 in Review

Pathstone Holdings sold out of CryoPort (CYRX) in Q1 2024, closing a stake of 11,903 shares — an estimated $184K sold.

Pathstone Holdings first reported a position in CYRX in Q4 2023 and held it in 1 quarter. The position peaked at $184K in Q4 2023. 150 funds tracked by Wall St. Rank hold CYRX as of Q1 2024.

Pathstone Holdings reported no remaining CryoPort position as of Q1 2024 after selling out during the quarter.
Pathstone Holdings sold 11,903 CryoPort shares in Q1 2024, an estimated $184K.
Pathstone Holdings first reported a position in CryoPort in Q4 2023 and held it in 1 quarter.
Pathstone Holdings's CryoPort position peaked at $184K in Q4 2023.
150 funds tracked by Wall St. Rank held CryoPort as of Q1 2024.

Based on Pathstone Holdings's 13F filing for Q1 2024, filed 13 May 2024.